主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SNTI
#4018
Senti Biosciences, Inc. Common Stock
0.931
5
USD
-6.40%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-6.40%
每月变动
-2.15%
6个月变化
-2.15%
年变化
-2.15%
前一天收盘价
0.995
2
Open
0.931
5
Bid
0.931
5
Ask
0.934
5
Low
0.931
5
High
0.931
5
交易量
6
市场
股票
医疗保健
SNTI
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
2.95 M
4.42 M
4.58 M
26 M
—
Valuation ratios
Enterprise value
—
—
—
42.98 M
155.28 M
Price to earnings ratio
—
—
—
-0.29
-1.27
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
-0.39
-1.38
Price to book ratio
—
—
—
0.63
1.05
Enterprise value to EBITDA ratio
—
—
—
-0.7
—
Profitability ratios
Return on assets %
—
0.32
0.6
0.54
0.74
Return on equity %
—
0.46
1.06
2.06
3.23
Return on invested capital %
—
206.69
541.24
495.63
—
Gross margin %
—
100
100
—
—
Operating margin %
—
1 647.9
3 620.73
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
1 358.14
2 776.26
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
0.4
5.68
5.62
4.49
13.47
Inventory turnover
—
—
—
—
—
Asset turnover
—
0.02
0.02
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
13.36
11.81
9.01
5.2
EBIT per share
—
—
—
-14.11
—
EBITDA per share
—
—
—
-13.27
—
Total debt per share
—
—
—
—
—
Cash per share
—
37.76
8.09
10.51
15.18
Net current asset value per share
—
39.29
16.05
12.83
19.28
Tangible book value per share
—
48.74
15.08
5.58
10.62
Working capital per share
—
32.37
13.19
9.97
14.51
Book value per share
—
48.74
15.08
5.58
10.62
新闻
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories! - TipRanks.com
Why Is Gene Therapy Focused Senti Bio Stock Falling Today? - Senti Biosciences (NASDAQ:SNTI)
Senti Bio的SENTI-202在AML临床试验中显示出有希望的结果
Senti Bio’s SENTI-202 shows promising results in AML clinical trial
Senti Bio股价在癌症疗法试验结果积极后飙升
Senti Bio stock soars after positive cancer therapy trial results
Leerink Partners 以"跑赢大盘"评级开启对 Senti Biosciences 股票的覆盖
Senti Bio将在ASH会议上展示SENTI-202的最新临床数据
Senti Bio to present updated clinical data on SENTI-202 at ASH meeting
H.C. Wainwright 给 Senti Biosciences 股票评级为"买入"
Senti Biosciences stock rating initiated at Buy by H.C. Wainwright
Senti Biosciences completes dose finding in AML therapy trial